Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The intestine as a regulator of cholesterol homeostasis in diabetes.

Tomkin GH.

Atheroscler Suppl. 2008 Sep;9(2):27-32. doi: 10.1016/j.atherosclerosissup.2008.05.012. Epub 2008 Aug 6. Review.

PMID:
18693145
3.

Dyslipidaemia--hepatic and intestinal cross-talk.

Tomkin GH.

Atheroscler Suppl. 2010 Jun;11(1):5-9. doi: 10.1016/j.atherosclerosissup.2010.03.005. Review.

PMID:
20434963
4.

Dyslipidaemia of diabetes and the intestine.

Tomkin GH, Owens D.

World J Diabetes. 2015 Jul 10;6(7):970-7. doi: 10.4239/wjd.v6.i7.970. Review.

6.
7.

Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.

Phillips C, Bennett A, Anderton K, Owens D, Collins P, White D, Tomkin GH.

Metabolism. 2002 Jul;51(7):847-52.

PMID:
12077729
8.

Model of intestinal chylomicron over-production and ezetimibe treatment: impact on the retention of cholesterol in arterial vessels.

Mangat R, Warnakula S, Wang Y, Russell JC, Uwiera R, Vine DF, Proctor SD.

Atheroscler Suppl. 2010 Jun;11(1):17-24. doi: 10.1016/j.atherosclerosissup.2010.04.043. Epub 2010 May 14. Review.

PMID:
20471328
9.

Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein.

Xie Y, Kennedy S, Sidhu R, Luo J, Ory DS, Davidson NO.

Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1624-31. doi: 10.1161/ATVBAHA.112.246066. Epub 2012 May 10.

10.

Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?

Phillips C, Madigan C, Owens D, Collins P, Tomkin GH.

Int J Exp Diabetes Res. 2002 Jul-Sep;3(3):171-8.

11.

The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model.

Gleeson A, Owens D, Collins P, Johnson A, Tomkin GH.

Int J Exp Diabetes Res. 2000;1(3):203-10.

12.

The chylomicron: relationship to atherosclerosis.

Tomkin GH, Owens D.

Int J Vasc Med. 2012;2012:784536. doi: 10.1155/2012/784536. Epub 2011 Oct 5.

13.

Intestinal and hepatic cholesterol carriers in diabetic Psammomys obesus.

Levy E, Lalonde G, Delvin E, Elchebly M, Précourt LP, Seidah NG, Spahis S, Rabasa-Lhoret R, Ziv E.

Endocrinology. 2010 Mar;151(3):958-70. doi: 10.1210/en.2009-0866. Epub 2010 Feb 3.

PMID:
20130116
14.

Targets for intervention in dyslipidemia in diabetes.

Tomkin GH.

Diabetes Care. 2008 Feb;31 Suppl 2:S241-8. doi: 10.2337/dc08-s260. Review.

PMID:
18227492
15.

Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?

Battula SB, Fitzsimons O, Moreno S, Owens D, Collins P, Johnson A, Tomkin GH.

Metabolism. 2000 Aug;49(8):1049-54.

PMID:
10954025
16.
17.

The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.

Taggart C, Gibney J, Owens D, Collins P, Johnson A, Tomkin GH.

Diabet Med. 1997 Dec;14(12):1051-8.

PMID:
9455933
18.
19.

Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome.

Arca M.

Atheroscler Suppl. 2015 Feb;17:12-6. doi: 10.1016/S1567-5688(15)50004-4. Review.

PMID:
25659871
20.

ABCG5/ABCG8 in cholesterol excretion and atherosclerosis.

Yu XH, Qian K, Jiang N, Zheng XL, Cayabyab FS, Tang CK.

Clin Chim Acta. 2014 Jan 20;428:82-8. doi: 10.1016/j.cca.2013.11.010. Epub 2013 Nov 16. Review.

PMID:
24252657
Items per page

Supplemental Content

Write to the Help Desk